Insmed to Host Third-Quarter 2025 Financial Results Conference Call on Thursday, October 30, 2025

Rhea-AI Summary

Insmed (Nasdaq: INSM) will release its third-quarter 2025 financial results on Thursday, October 30, 2025. Management will host a conference call for investors at 8:00 a.m. ET the same day to discuss results and provide a business update.

Investors may dial (888) 210-2654 (U.S.) or (646) 960-0278 (international) using access code 7862189, or listen via live webcast at www.insmed.com. A replay will be available about one hour after the call through November 6, 2025 by dialing (800) 770-2030 (U.S.) or (609) 800-9909 (international) with access code 7862189. The webcast will be archived for 90 days under the Investor Relations section of the company website.

BRIDGEWATER, N.J., Oct. 15, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its third-quarter 2025 financial results on Thursday, October 30, 2025.

Insmed management will host a conference call for investors beginning at 8:00 a.m. ET on Thursday, October 30, 2025, to discuss financial results and provide a business update.

Shareholders and other interested parties may participate in the conference call by dialing (888) 210-2654 (U.S.) and (646) 960-0278 (international) and referencing access code 7862189. The call will also be webcast live on the Company's website at www.insmed.com.

A replay of the conference call will be accessible approximately 1 hour after its completion through November 6, 2025, by dialing (800) 770-2030 (U.S.) and (609) 800-9909 (international) and referencing access code 7862189. A webcast of the call will also be archived for 90 days under the Investor Relations section of the Company's website at www.insmed.com.

About Insmed

Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including two therapies approved to treat chronic, debilitating lung diseases. The Company's early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.

Headquartered in Bridgewater, New Jersey, Insmed has offices and research locations throughout the United States, Europe, and Japan. Insmed is proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending four consecutive years as the No. 1 Science Top Employer. Visit www.insmed.com to learn more or follow us on LinkedIn, Instagram, YouTube, and X.

Contact:

Investors:

Bryan Dunn
Vice President, Investor Relations
(646) 812-4030
investor.relations@insmed.com

Media:

Claire Mulhearn
Vice President, Corporate Communications
(862) 842-6819
media@insmed.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-host-third-quarter-2025-financial-results-conference-call-on-thursday-october-30-2025-302583906.html

SOURCE Insmed Incorporated

FAQ

When will Insmed (INSM) release its Q3 2025 financial results?

Insmed will release its Q3 2025 results on Thursday, October 30, 2025.

What time is the Insmed (INSM) Q3 2025 conference call and how can I join?

The call begins at 8:00 a.m. ET on October 30, 2025; dial (888) 210-2654 (U.S.) or (646) 960-0278 (international) and use access code 7862189, or join the live webcast at www.insmed.com.

Will there be a replay of the Insmed (INSM) October 30, 2025 earnings call?

Yes. A replay will be available about one hour after the call through November 6, 2025 by dialing (800) 770-2030 (U.S.) or (609) 800-9909 (international) with access code 7862189.

Where can investors find the Insmed (INSM) earnings webcast archive?

The webcast will be archived for 90 days in the Investor Relations section at www.insmed.com.

What will Insmed (INSM) management discuss on the October 30, 2025 call?

Management will discuss the third-quarter 2025 financial results and provide a company business update.